Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada...
December 2, 2021
by WorldPharmaNews
Eurofins Discovery Launches Human Immune Models for COVID-19 New Therapeutic Discovery or Repurposing
Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces the launch of new services in support of clients working to ...
May 19, 2021
by prnasia
Serimmune Opens Enrollment for COVID-19 Immune Response Study
Serimmune, Inc. announced that the company is enrolling 2,000 research participants in a study designed to understand the human immune response to SARS-CoV-2, the virus that causes COVID-19.
April 14, 2021
by prnewswire
Scottish COVID-19 vaccine shows ‘strong immune response’ in early UK trials
The vaccine, called VLA2001, also induced T-cell responses, which help the body fend off a virus and determine long-lasting immunity.
April 8, 2021
by expresspharma
New findings help explain how COVID-19 overpowers the immune system
Seeking to understand why COVID-19 is able to suppress the body's immune response, new research from the USC Leonard Davis School of Gerontology suggests that mitochondria are one of the first lines of defense against COVID-19 and identifies key ...
January 13, 2021
by worldpharmanews
DPX-COVID-19 has potential to improve duration of immune response
On October 8, Canada-based biotech company, IMV, which is soon to publish pre-clinical data on DPX-COVID-19, its immunotherapy-based vaccine candidate for the prevention of SARS-COV-2, announced that to increase its current manufacturing capacity ...
October 21, 2020
by expresspharma
J&J COVID-19 vaccine candidate yields strong immune response in early trial
Immune response results were available from only 15 people over 65 years old, limiting the interpretation.
September 27, 2020
by expresspharma
Which immune response could cause a vaccine against COVID-19?
Immune reactions caused by vaccination can help protect the organism, or sometimes may aggravate the condition. It is especially important now when multiple vaccines against COVID-19 are being developed.
September 15, 2020
by worldpharmanews
Further £8.4 million in funding given to UK researchers studying immune response to COVID-19
The funding is being split across three research projects that will hopefully improve the treatment of COVID-19 and inform the development of vaccines and therapeutics.
August 31, 2020
by europeanpharmaceuticalreview
University of Sheffield joins UK Coronavirus Immunology Consortium for COVID-19 research
The Sheffield team will investigate how the body’s immune system responds to infection and also examine how T cells contribute to immunity to the virus to prevent re-infection.
August 31, 2020
by expresspharma
Moderna informs COVID-19 vaccine induced immune response in older adults in small study
The latest data from an early Phase I study includes an analysis from 20 additional people detailing how the vaccine performed in older adults.
August 27, 2020
by expresspharma
Translate Bio, Sanofi Covid-19 vaccine elicits immune response in animals
Translate Bio has reported that its Covid-19 vaccine candidate, being developed in collaboration with Sanofi, elicited immune response in early-stage animal studies.
August 26, 2020
by pharmaceutical-technology